Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. experienced notable intraday gains, contrasting with a decline in the broader market. However, the company's longer-term performance has faced challenges, with significant decreases over the past month and year. Key financial metrics include a market capitalization of CNY 343,782 million and a price-to-earnings ratio of 57.00.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. saw a significant stock decline today, contrasting with a slight increase in the China Shanghai Composite. Over the past week, month, and year, the stock has faced notable decreases, reflecting ongoing challenges in growth within the competitive pharmaceuticals sector.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. saw a significant stock decline today, contrasting with the broader market's performance. Over the past week and month, the stock has faced challenges, although it has shown positive annual growth. The company maintains a strong market capitalization and financial metrics, despite pressures on profitability.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. experienced notable intraday gains, contrasting with the modest rise of the China Shanghai Composite. Despite recent daily increases, the company has faced declines over the past week and month, while its annual return remains positive. The firm holds a significant market capitalization and key financial metrics.